NDC 10157-1134 Blistex Global Blend

Blistex Global Blend with NDC 10157-1134 is a a human over the counter drug product labeled by Blistex Inc.. The generic name of Blistex Global Blend is dimethicone, octinoxate, and octisalate. The product's dosage form is stick and is administered via topical form.

Dosage Form: Stick - A dosage form prepared in a relatively long and slender often cylindrical form.

Product Type: Human Otc Drug What kind of product is this?
Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.

Blistex Global Blend Active Ingredient(s)

What is the Active Ingredient(s) List?
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.

• DIMETHICONE 2 g/100g
• OCTINOXATE 6.6 g/100g
• OCTISALATE 4.4 g/100g

Inactive Ingredient(s)

About the Inactive Ingredient(s)
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product.

• PETROLATUM (UNII: 4T6H12BN9U)
• PENTAERYTHRITYL TETRAETHYLHEXANOATE (UNII: XJ7052W897)
• MICROCRYSTALLINE WAX (UNII: XOF597Q3KY)
• HYDROGENATED JOJOBA OIL, RANDOMIZED (UNII: Q47ST02F58)
• MYRISTYL MYRISTATE (UNII: 4042ZC00DY)
• HYDROGENATED POLYBUTENE (1300 MW) (UNII: 7D1YQ9Y5EZ)
• OCTYLDODECANOL (UNII: 461N1O614Y)
• WHITE WAX (UNII: 7G1J5DA97F)
• CASTOR OIL (UNII: D5340Y2I9G)
• STEARYL DIMETHICONE (400 MPA.S AT 50C) (UNII: R327X197HY)
• MANGIFERA INDICA SEED BUTTER (UNII: 4OXD9M35X2)
• PEARL (HYRIOPSIS CUMINGII) (UNII: A75L5FZ40U)
• JOJOBA OIL (UNII: 724GKU717M)
• .ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)
• MICA (UNII: V8A1AW0880)
• TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
• PHENOXYETHANOL (UNII: HIE492ZZ3T)
• SACCHARIN (UNII: FST467XS7D)
• SORBIC ACID (UNII: X045WJ989B)

Administration Route(s)

What are the Administration Route(s)?
The translation of the route code submitted by the firm, indicating route of administration.

• Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.

Product Labeler Information

What is the Labeler Name?
Name of Company corresponding to the labeler code segment of the Product NDC.

Labeler Name: Blistex Inc.
Labeler Code: 10157
FDA Application Number: part352 What is the FDA Application Number?
This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
Marketing Category: OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph. What is the Marketing Category?
Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Start Marketing Date: 07-01-2018 What is the Start Marketing Date?
This is the date that the labeler indicates was the start of its marketing of the drug product.
Listing Expiration Date: 12-31-2021 What is the Listing Expiration Date?
This is the date when the listing record will expire if not updated or certified by the product labeler.
Exclude Flag: N - NO What is the NDC Exclude Flag?
This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".

* Please review the disclaimer below.